Global Glucosamine amp Chondroitin Supplements Market Size By Type (Liquid, Tablets), By Application (Retailer, Online Shopping), By Region, And Segment Forecasts, 2023 to 2032

The Global Glucosamine & Chondroitin Supplements Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 5.3 billion by 2031, expanding at a CAGR of 7.1% during the forecast period from 2023 to 2031. The increasing prevalence of osteoarthritis and joint-related disorders among the aging population is a primary driver fueling demand for these supplements. Consumers are increasingly opting for preventive health approaches and natural alternatives to pharmaceuticals, enhancing the adoption of glucosamine and chondroitin formulations. Additionally, growing awareness of joint health, rising healthcare expenditures, and product innovations in capsule, tablet, and powder forms contribute to market growth.

Drivers:

1. Rising Prevalence of Joint Disorders:

With aging populations globally, particularly in developed nations, osteoarthritis and degenerative joint conditions are becoming more common. Glucosamine and chondroitin are widely recognized for their role in joint health, creating sustained consumer demand.

2. Increasing Preference for Preventive Healthcare:

Consumers are increasingly focusing on preventive measures, seeking dietary supplements that promote long-term joint flexibility and mobility, fueling consistent market growth.

3. Product Innovation and Accessibility:

The availability of glucosamine and chondroitin supplements in diverse delivery formats (e.g., gummies, powders, vegan options) has broadened consumer appeal and accessibility, especially in e-commerce platforms.

Restraints:

1. Lack of Clinical Consensus:

Despite wide usage, clinical trials yield mixed results regarding the efficacy of glucosamine and chondroitin, which may create skepticism among healthcare providers and consumers.

2. Regulatory and Labeling Challenges:

Variations in dietary supplement regulations across different countries and concerns about mislabeling or unverified health claims may hamper growth and market penetration.

Opportunities:

1. Expansion in Emerging Economies:

The growing middle-class population and rising awareness of joint health in regions such as Asia-Pacific and Latin America offer significant untapped potential.

2. Rising Demand for Vegan and Plant-Based Alternatives:

As plant-based trends grow, there is increasing consumer interest in vegan glucosamine and chondroitin alternatives derived from fungi or algae, representing a lucrative product development opportunity.

Market by System Type Insights:

Based on product type, the glucosamine sulfate segment led the market in 2023, attributed to its proven absorption rates and efficacy in joint repair and pain relief. Meanwhile, combination formulations of glucosamine and chondroitin are rapidly gaining traction, offering synergistic benefits and catering to consumers seeking comprehensive joint support solutions.

Market by End-use Insights:

In terms of end-use, the adult segment (aged 45 and above) held the largest market share in 2023. This demographic represents the primary consumer base due to the higher incidence of arthritis and joint stiffness. However, the sports nutrition segment is expected to register the highest growth, driven by increasing adoption among athletes and fitness enthusiasts for joint recovery and injury prevention.

Market by Regional Insights:

North America dominated the global market in 2023, supported by high health awareness, advanced distribution channels, and a well-established supplement industry. Asia-Pacific, however, is anticipated to experience the highest growth rate during the forecast period, driven by rapid urbanization, an aging population, and the increasing adoption of Western health trends.

Competitive Scenario:

Leading companies in the global glucosamine & chondroitin supplements market include Schiff Nutrition (Reckitt Benckiser), NOW Foods, Nature’s Bounty, GNC Holdings, Nutramax Laboratories, Swisse Wellness, Jarrow Formulas, Doctor’s Best, Solgar Inc., and Kirkland Signature. These players focus on new product launches, clean-label formulations, and expanding their online retail presence. For instance:

In 2024, Nutramax Laboratories launched a triple-strength glucosamine-chondroitin complex targeting osteoarthritis patients.

NOW Foods introduced a vegan-friendly glucosamine supplement in 2023 using shellfish-free sources to cater to allergen-sensitive consumers.

Schiff Nutrition partnered with a leading e-commerce platform in 2025 to enhance digital reach and global distribution.

Scope of Work – Global Glucosamine & Chondroitin Supplements Market

Key Market Developments:

2023: NOW Foods introduced glucosamine products free from shellfish, targeting vegan consumers.

2024: Nutramax Laboratories launched enhanced-strength supplements backed by clinical studies on joint pain reduction.

2025: GNC expanded its global footprint with a digital-first product rollout focused on mobility supplements.

FAQs:

1) What is the current market size of the Global Glucosamine & Chondroitin Supplements Market?

The market was valued at USD 3.1 billion in 2023.

2) What is the major growth driver of the Global Glucosamine & Chondroitin Supplements Market?

The major growth driver is the rising global incidence of joint-related disorders and the growing preference for natural, preventive joint health solutions.

3) Which is the largest region during the forecast period in the Global Glucosamine & Chondroitin Supplements Market?

North America held the largest share in 2023, but Asia-Pacific is projected to grow fastest during the forecast period.

4) Which segment accounted for the largest market share in the Global Glucosamine & Chondroitin Supplements Market?

The glucosamine sulfate segment accounted for the largest market share by product type.

5) Who are the key market players in the Global Glucosamine & Chondroitin Supplements Market?

Key players include Schiff Nutrition, NOW Foods, GNC Holdings, Nutramax Laboratories, Nature’s Bounty, and Solgar Inc.